MAFFEI, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.873
AS - Asia 3.668
EU - Europa 3.418
SA - Sud America 440
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 87
OC - Oceania 38
Totale 16.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.699
GB - Regno Unito 1.034
SG - Singapore 968
CN - Cina 813
HK - Hong Kong 799
IT - Italia 742
VN - Vietnam 414
SE - Svezia 369
DE - Germania 337
BR - Brasile 325
BD - Bangladesh 209
FI - Finlandia 200
RU - Federazione Russa 166
UA - Ucraina 135
FR - Francia 123
TR - Turchia 99
CA - Canada 93
IN - India 72
KR - Corea 61
BG - Bulgaria 51
ID - Indonesia 49
NL - Olanda 44
ES - Italia 40
AU - Australia 38
IE - Irlanda 31
AR - Argentina 29
JP - Giappone 28
ZA - Sudafrica 27
BE - Belgio 26
IQ - Iraq 24
MX - Messico 24
PL - Polonia 23
CL - Cile 21
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 19
PK - Pakistan 17
MA - Marocco 16
PH - Filippine 15
VE - Venezuela 14
EC - Ecuador 13
JM - Giamaica 13
UZ - Uzbekistan 13
CO - Colombia 12
AT - Austria 11
RO - Romania 11
CR - Costa Rica 10
MY - Malesia 10
PE - Perù 10
CH - Svizzera 9
DK - Danimarca 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 8
PY - Paraguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
SA - Arabia Saudita 6
BZ - Belize 5
DO - Repubblica Dominicana 5
PR - Porto Rico 5
TW - Taiwan 5
BO - Bolivia 4
GR - Grecia 4
HN - Honduras 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BY - Bielorussia 3
CY - Cipro 3
HR - Croazia 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BS - Bahamas 1
Totale 16.509
Salva come PNG Salva come JPEG
Città #
Ashburn 835
Ann Arbor 792
Hong Kong 791
Fairfield 784
Southend 733
Santa Clara 646
Singapore 576
Woodbridge 469
Houston 418
Chandler 415
San Jose 329
Seattle 314
Cambridge 272
Wilmington 246
Nyköping 243
Jacksonville 215
Hefei 199
Council Bluffs 198
Dearborn 196
Los Angeles 168
Chicago 159
Beijing 157
Helsinki 150
London 146
Modena 145
New York 129
Ho Chi Minh City 123
Hanoi 98
Milan 88
Munich 71
The Dalles 68
Salt Lake City 63
San Diego 61
Seoul 59
Fremont 57
Princeton 55
Lauterbourg 51
Sofia 51
Eugene 46
Izmir 45
Moscow 45
Buffalo 41
Columbus 40
Dallas 37
Rome 36
Bologna 35
Bremen 35
Jakarta 35
Tampa 33
Dublin 31
Frankfurt am Main 28
Orem 28
Atlanta 27
Phoenix 27
Brussels 26
Shanghai 25
São Paulo 25
Elk Grove Village 24
Boardman 23
Redwood City 23
Melbourne 22
Toronto 21
Miami 20
Warsaw 20
Des Moines 19
Tokyo 19
Da Nang 18
Lancaster 18
Montreal 18
Brooklyn 16
Chennai 15
Haiphong 15
Denver 14
Dong Ket 14
Falls Church 14
Vancouver 14
Brno 13
Tashkent 13
Miano 12
Reggio Emilia 12
Amsterdam 11
Bari 11
Dulles 11
Jinan 11
Naples 11
North Bergen 11
Rio de Janeiro 11
Ankara 10
Baghdad 10
Boston 10
Guangzhou 10
Johannesburg 10
Kent 10
Madrid 10
Ninh Bình 10
Perugia 10
Turku 10
Kilburn 9
Ottawa 9
Plano 9
Totale 11.816
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 831
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 607
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 441
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 424
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 394
Mucorales-specific T cells in patients with hematologic malignancies 380
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 377
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 372
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 367
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 361
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 354
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 346
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 340
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 338
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 333
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 331
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 329
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 324
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 318
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 314
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 313
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 311
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 307
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 305
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 304
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 301
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 301
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 295
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 286
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 286
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 284
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 282
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 281
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 281
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 279
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 276
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 271
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study 269
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 268
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 259
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 254
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. 248
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 248
HOXA homeogene cluster interruption and dysregulation of HOAX9 in the blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. 242
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 233
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 204
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. 198
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 183
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. 177
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 177
Performance trade-offs of different rake receivers 167
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 160
NOX-A12: Mobilizing CLL away from home 144
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 123
The dynamic functions of IRF4 in B cell malignancies 113
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 37
GENOMIC SCREENING OF PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA WITHOUT TP53 ALTERATIONS BY OPTICAL GENOME MAPPING (OGM) 36
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 22
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia 14
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 14
Totale 16.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022859 0 0 93 46 29 82 53 53 97 84 215 107
2022/20231.247 128 156 103 114 168 164 15 145 134 12 53 55
2023/2024800 28 36 51 85 149 68 86 110 15 24 63 85
2024/20252.728 82 49 29 194 409 354 180 135 610 129 217 340
2025/20265.551 337 703 324 594 871 326 613 219 464 451 323 326
2026/2027435 140 280 15 0 0 0 0 0 0 0 0 0
Totale 16.634